ITMI20020681A1 - Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina - Google Patents
Procedimento per la produzione di nanoparticelle di paclitaxel ed albuminaInfo
- Publication number
- ITMI20020681A1 ITMI20020681A1 IT2002MI000681A ITMI20020681A ITMI20020681A1 IT MI20020681 A1 ITMI20020681 A1 IT MI20020681A1 IT 2002MI000681 A IT2002MI000681 A IT 2002MI000681A IT MI20020681 A ITMI20020681 A IT MI20020681A IT MI20020681 A1 ITMI20020681 A1 IT MI20020681A1
- Authority
- IT
- Italy
- Prior art keywords
- albumina
- paclitaxel
- nanoparticles
- procedure
- production
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5169—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Epoxy Compounds (AREA)
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002MI000681A ITMI20020681A1 (it) | 2002-03-29 | 2002-03-29 | Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina |
EP03004629A EP1348431A1 (en) | 2002-03-29 | 2003-03-03 | Process for producing nanoparticles of paclitaxel and albumin |
IL15476203A IL154762A0 (en) | 2002-03-29 | 2003-03-05 | Process for producing nanoparticles of paclitaxel and albumin |
AU2003200920A AU2003200920A1 (en) | 2002-03-29 | 2003-03-05 | Process for producing nanoparticles of paclitaxel and albumin |
NZ524605A NZ524605A (en) | 2002-03-29 | 2003-03-07 | Process for producing nanoparticles of paclitaxel and albumin |
US10/383,639 US20030185894A1 (en) | 2002-03-29 | 2003-03-10 | Process for producing nanoparticles of paclitaxel and albumin |
ZA200302040A ZA200302040B (en) | 2002-03-29 | 2003-03-13 | Process for producing nanoparticles of paclitaxel and albumin. |
JP2003070028A JP4794115B2 (ja) | 2002-03-29 | 2003-03-14 | パクリタキセルおよびアルブミンのナノ粒子を作製する方法 |
MXPA03002543A MXPA03002543A (es) | 2002-03-29 | 2003-03-24 | Proceso para producir nanoparticulas de paclitaxel y albumina. |
BR0300846-0A BR0300846A (pt) | 2002-03-29 | 2003-03-26 | Processo para produzir nanopartìculas de paclitaxel e albumina |
KR10-2003-0019242A KR20030078722A (ko) | 2002-03-29 | 2003-03-27 | 파클리탁셀 및 알부민의 나노입자의 제조방법 |
CA002423915A CA2423915A1 (en) | 2002-03-29 | 2003-03-28 | Process for producing nanoparticles of paclitaxel and albumin |
NO20031448A NO334407B1 (no) | 2002-03-29 | 2003-03-28 | Fremgangsmåte for fremstilling av et sterilt, lyofilisert pulver bestående av nanopartikler av paclitaxel og humant serumalbumin |
RU2003108821/15A RU2003108821A (ru) | 2002-03-29 | 2003-03-28 | Способ получения наночастиц паклитаксела и альбумина |
CNB031083617A CN1259902C (zh) | 2002-03-29 | 2003-03-28 | 制造紫杉醇和白蛋白的纳米颗粒的方法 |
CNA2006100770064A CN1911446A (zh) | 2002-03-29 | 2003-03-28 | 制备紫杉醇和白蛋白的纳米颗粒的方法 |
US11/334,004 US20060121119A1 (en) | 2002-03-29 | 2006-01-17 | Process for producing nanoparticles of paclitaxel and albumin |
JP2011043799A JP2011132253A (ja) | 2002-03-29 | 2011-03-01 | パクリタキセルおよびアルブミンのナノ粒子を作製する方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002MI000681A ITMI20020681A1 (it) | 2002-03-29 | 2002-03-29 | Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina |
Publications (2)
Publication Number | Publication Date |
---|---|
ITMI20020681A0 ITMI20020681A0 (it) | 2002-03-29 |
ITMI20020681A1 true ITMI20020681A1 (it) | 2003-09-29 |
Family
ID=11449619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT2002MI000681A ITMI20020681A1 (it) | 2002-03-29 | 2002-03-29 | Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina |
Country Status (15)
Country | Link |
---|---|
US (2) | US20030185894A1 (it) |
EP (1) | EP1348431A1 (it) |
JP (2) | JP4794115B2 (it) |
KR (1) | KR20030078722A (it) |
CN (2) | CN1259902C (it) |
AU (1) | AU2003200920A1 (it) |
BR (1) | BR0300846A (it) |
CA (1) | CA2423915A1 (it) |
IL (1) | IL154762A0 (it) |
IT (1) | ITMI20020681A1 (it) |
MX (1) | MXPA03002543A (it) |
NO (1) | NO334407B1 (it) |
NZ (1) | NZ524605A (it) |
RU (1) | RU2003108821A (it) |
ZA (1) | ZA200302040B (it) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070117863A1 (en) * | 1993-02-22 | 2007-05-24 | Desai Neil P | Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
US20030133955A1 (en) * | 1993-02-22 | 2003-07-17 | American Bioscience, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
US20070092563A1 (en) * | 1996-10-01 | 2007-04-26 | Abraxis Bioscience, Inc. | Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
US20030199425A1 (en) * | 1997-06-27 | 2003-10-23 | Desai Neil P. | Compositions and methods for treatment of hyperplasia |
US8853260B2 (en) * | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
CN100462066C (zh) * | 1997-06-27 | 2009-02-18 | 美国生物科学有限公司 | 药剂的新制剂及其制备和应用方法 |
SI1585548T1 (sl) | 2002-12-09 | 2018-11-30 | Abraxis Bioscience, Llc | Sestave in metode odmerjanja farmakoloških sredstev |
SI3248600T1 (sl) | 2005-02-18 | 2020-09-30 | Abraxis Bioscience, Llc | Kombinacije in načini dajanja terapevtskih sredstev in kombinacijska terapija |
US8735394B2 (en) | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
CN101287507B (zh) * | 2005-08-12 | 2012-12-05 | 刘江 | 用于淋巴靶向的方法和装置 |
CN101291658B (zh) | 2005-08-31 | 2014-04-16 | 阿布拉科斯生物科学有限公司 | 用于制备稳定性增加的水难溶性药物的组合物和方法 |
HUE048521T2 (hu) * | 2005-08-31 | 2020-08-28 | Abraxis Bioscience Llc | Gyengén vízoldékony gyógyszerészeti és antimikrobális hatóanyagokat tartalmazó keverékek |
AR054215A1 (es) * | 2006-01-20 | 2007-06-13 | Eriochem Sa | Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit |
EP1870649A1 (en) | 2006-06-20 | 2007-12-26 | Octapharma AG | Lyophilisation targetting defined residual moisture by limited desorption energy levels |
US20080280987A1 (en) * | 2006-08-31 | 2008-11-13 | Desai Neil P | Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases |
PT2229148E (pt) * | 2007-12-13 | 2014-05-26 | Novartis Ag | Processo para preparação de uma substância farmacológica particulada e substancialmente cristalina |
MX2010011165A (es) * | 2008-04-10 | 2011-02-22 | Abraxis Bioscience Llc | Composiciones de derivados de taxano hidrofobos y sus usos. |
EP2156823A1 (en) * | 2008-08-14 | 2010-02-24 | Pharmatex Italia Srl | Process for the preparation of sterile powdered pharmeceutical compounds in the form of micro and nanoparticles |
CN101658516B (zh) * | 2008-08-26 | 2011-10-05 | 齐鲁制药有限公司 | 紫杉醇类药物组合物及其制备方法 |
US20100297243A1 (en) | 2009-04-15 | 2010-11-25 | Desai Neil P | Prion free nanoparticle compositions and methods of making thereof |
WO2011017835A1 (en) * | 2009-08-11 | 2011-02-17 | Nanjing University | Preparation method of protein or peptide nanoparticles for in vivo drug delivery by unfolding and refolding |
US20130058965A1 (en) * | 2009-12-31 | 2013-03-07 | Mannkind Corporation | Injectable formulations for parenteral administration |
LT2552438T (lt) | 2010-03-26 | 2016-09-26 | Abraxis Bioscience, Llc | Hepatoceliulinės karcinomos gydymo būdai |
KR20130028727A (ko) | 2010-03-29 | 2013-03-19 | 아브락시스 바이오사이언스, 엘엘씨 | 치료제의 약물 전달 및 유효성 향상 방법 |
LT2552415T (lt) | 2010-03-29 | 2016-12-27 | Abraxis Bioscience, Llc | Vėžio gydymo būdai |
KR100971087B1 (ko) * | 2010-05-06 | 2010-07-16 | 김현수 | 불투명부에 암막기능을 갖는 블라인드지의 제직방법 |
RU2576609C2 (ru) | 2010-06-04 | 2016-03-10 | АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи | Способы лечение рака поджелудочной железы |
CN102274190B (zh) * | 2010-06-11 | 2012-12-05 | 上海现代药物制剂工程研究中心有限公司 | 一种注射用紫杉醇白蛋白亚微粒及其制备方法 |
CN102078306A (zh) * | 2011-01-11 | 2011-06-01 | 无锡圆容生物医药股份有限公司 | 一种含有重组人血白蛋白的紫杉醇纳米颗粒冷冻干燥制剂 |
SI2790675T1 (sl) | 2011-12-14 | 2019-11-29 | Abraxis Bioscience Llc | Uporaba polimernih pomožnih snovi za liofilizacijo ali zamrzovanje delcev |
US20150110864A1 (en) | 2012-03-16 | 2015-04-23 | Taiho Pharmaceutical Co., Ltd. | Novel antitumor agent comprising combination of three agents |
US9149455B2 (en) | 2012-11-09 | 2015-10-06 | Abraxis Bioscience, Llc | Methods of treating melanoma |
US9511046B2 (en) * | 2013-01-11 | 2016-12-06 | Abraxis Bioscience, Llc | Methods of treating pancreatic cancer |
CN105228612A (zh) | 2013-03-12 | 2016-01-06 | 阿布拉科斯生物科学有限公司 | 治疗肺癌的方法 |
RU2015143490A (ru) | 2013-03-14 | 2017-04-26 | АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи | Способы лечения рака мочевого пузыря |
US10527604B1 (en) | 2015-03-05 | 2020-01-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel |
US10705070B1 (en) | 2015-03-05 | 2020-07-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug |
EA202092187A1 (ru) | 2015-06-29 | 2021-08-31 | АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи | Способы лечения эпителиоидно-клеточных опухолей |
CN105012251A (zh) * | 2015-08-24 | 2015-11-04 | 吉林大学 | 注射用紫杉烷类药物白蛋白纳米粒冻干制剂及制备方法 |
WO2018048958A1 (en) * | 2016-09-06 | 2018-03-15 | Mayo Foundation For Medical Education And Research | Paclitaxel-albumin-binding agent compositions and methods for using and making the same |
CN109789226B (zh) * | 2016-09-27 | 2021-11-26 | 艾姆戈特株式会社 | 利用携带抗癌剂的人血清白蛋白纳米粒子的肝动脉化疗栓塞术用组合物及其制造方法 |
US11419842B2 (en) * | 2016-10-27 | 2022-08-23 | Zhuhai Beihai Biotech Co., Ltd. | Neutral pH compositions of Docetaxel and human serum albumin |
JP2021528362A (ja) | 2018-03-20 | 2021-10-21 | アブラクシス バイオサイエンス, エルエルシー | mTOR阻害剤およびアルブミンのナノ粒子の投与を介して中枢神経系障害を処置する方法 |
CN108524452A (zh) * | 2018-05-08 | 2018-09-14 | 辽宁大学 | 一种紫杉醇白蛋白纳米粒的制备方法和应用 |
CN110496111B (zh) * | 2018-05-18 | 2021-07-23 | 国家纳米科学中心 | 一种白蛋白纳米复合结构及其制备方法和应用 |
CN115003284A (zh) | 2019-10-28 | 2022-09-02 | 阿布拉科斯生物科学有限公司 | 白蛋白和雷帕霉素的药物组合物 |
CN110585444A (zh) * | 2019-10-31 | 2019-12-20 | 董军 | 一种中西医结合药物及其制备方法与应用 |
CN114681408B (zh) * | 2020-12-26 | 2023-06-23 | 四川汇宇制药股份有限公司 | 白蛋白结合型紫杉醇纳米粒的制备方法 |
KR102526793B1 (ko) * | 2021-11-03 | 2023-04-28 | 주식회사 에스엔바이오사이언스 | 입도분포 유지 안정성이 개선된 알부민 결합 탁산 나노입자 제조방법 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE264671T1 (de) * | 1993-02-22 | 2004-05-15 | American Bioscience Inc | Verfahren für die in-vivo-verabreichung von biologischen substanzen und hierfür verwendbare zusammensetzungen |
US5439686A (en) * | 1993-02-22 | 1995-08-08 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
US5362478A (en) * | 1993-03-26 | 1994-11-08 | Vivorx Pharmaceuticals, Inc. | Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell |
US6096331A (en) * | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
US5916596A (en) * | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
EP0998303B1 (en) * | 1997-06-12 | 2006-02-15 | Innovata PLC | Polymer-drug conjugate for the treatment of cancer |
CN100462066C (zh) * | 1997-06-27 | 2009-02-18 | 美国生物科学有限公司 | 药剂的新制剂及其制备和应用方法 |
EP1100494A1 (en) * | 1998-07-30 | 2001-05-23 | Novopharm Biotech, Inc. | Pharmaceutically composition comprising an aqueous solution of paclitaxel and albumin |
US20020041898A1 (en) * | 2000-01-05 | 2002-04-11 | Unger Evan C. | Novel targeted delivery systems for bioactive agents |
BR0110150A (pt) * | 2000-04-10 | 2004-04-27 | Teva Pharma | Método e composição para o tratamento de câncer por meio da administração de agentes quimioterápicos indutores da apoptose |
ITMI20001107A1 (it) * | 2000-05-18 | 2001-11-18 | Acs Dobfar Spa | Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel |
-
2002
- 2002-03-29 IT IT2002MI000681A patent/ITMI20020681A1/it unknown
-
2003
- 2003-03-03 EP EP03004629A patent/EP1348431A1/en not_active Withdrawn
- 2003-03-05 IL IL15476203A patent/IL154762A0/xx unknown
- 2003-03-05 AU AU2003200920A patent/AU2003200920A1/en not_active Abandoned
- 2003-03-07 NZ NZ524605A patent/NZ524605A/en not_active IP Right Cessation
- 2003-03-10 US US10/383,639 patent/US20030185894A1/en not_active Abandoned
- 2003-03-13 ZA ZA200302040A patent/ZA200302040B/xx unknown
- 2003-03-14 JP JP2003070028A patent/JP4794115B2/ja not_active Expired - Lifetime
- 2003-03-24 MX MXPA03002543A patent/MXPA03002543A/es unknown
- 2003-03-26 BR BR0300846-0A patent/BR0300846A/pt not_active Application Discontinuation
- 2003-03-27 KR KR10-2003-0019242A patent/KR20030078722A/ko not_active Application Discontinuation
- 2003-03-28 RU RU2003108821/15A patent/RU2003108821A/ru not_active Application Discontinuation
- 2003-03-28 CA CA002423915A patent/CA2423915A1/en not_active Abandoned
- 2003-03-28 NO NO20031448A patent/NO334407B1/no not_active IP Right Cessation
- 2003-03-28 CN CNB031083617A patent/CN1259902C/zh not_active Expired - Lifetime
- 2003-03-28 CN CNA2006100770064A patent/CN1911446A/zh active Pending
-
2006
- 2006-01-17 US US11/334,004 patent/US20060121119A1/en not_active Abandoned
-
2011
- 2011-03-01 JP JP2011043799A patent/JP2011132253A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
NZ524605A (en) | 2004-03-26 |
KR20030078722A (ko) | 2003-10-08 |
JP2003300878A (ja) | 2003-10-21 |
NO20031448L (no) | 2003-09-30 |
NO20031448D0 (no) | 2003-03-28 |
US20060121119A1 (en) | 2006-06-08 |
AU2003200920A1 (en) | 2003-10-16 |
CA2423915A1 (en) | 2003-09-29 |
NO334407B1 (no) | 2014-02-24 |
ZA200302040B (en) | 2003-09-17 |
US20030185894A1 (en) | 2003-10-02 |
MXPA03002543A (es) | 2005-08-26 |
JP2011132253A (ja) | 2011-07-07 |
IL154762A0 (en) | 2003-10-31 |
CN1911446A (zh) | 2007-02-14 |
BR0300846A (pt) | 2004-08-17 |
CN1448128A (zh) | 2003-10-15 |
EP1348431A1 (en) | 2003-10-01 |
RU2003108821A (ru) | 2004-11-10 |
JP4794115B2 (ja) | 2011-10-19 |
ITMI20020681A0 (it) | 2002-03-29 |
CN1259902C (zh) | 2006-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITMI20020681A1 (it) | Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina | |
CY2015015I1 (el) | Παραγωγη τιακουμυκινης | |
DE60310339D1 (de) | Querträger und Herstellungsverfahren | |
DE60225385D1 (de) | Autentisches Document und dessen Herstellungsverfahren | |
DE60319810D1 (de) | Anschwemmfiltermedien und herstellungs- und verwendungsverfahren | |
DE60324888D1 (de) | und Herstellungsverfahren | |
ATE517893T1 (de) | Arylvinylazacycloalkan-verbindungen sowie herstellungsverfahren dafür und verwendung davon | |
DE60334632D1 (de) | Mechanolumineszenzstoff und dessen herstellung | |
GB0608358D0 (en) | Fabrication of nanowires | |
GB0304623D0 (en) | Methods for the fabrication of nanoscale structures and semiconductor devices | |
ITBO20050705A1 (it) | Macchina per la fabbricazione e l'erogazione di frappe' di gelato o schake | |
ITFI20010103A0 (it) | Metodo ed attrezzatura per la produzione di mattonelle monostrato | |
ITBO20030349A1 (it) | Procedimento e macchina per la produzione di scatole di | |
ITUD20020222A1 (it) | Procedimento per la produzione di manufatti poliuretanici e relativo dispositivo | |
DE60323456D1 (de) | Herstellung von Nanopartikeln | |
DE602004006815D1 (de) | Monolithischer Halbleiterlaser und dessen Herstellungsverfahren | |
ITMI20042139A1 (it) | Procedimento per la produzione di cefepime e cefaposporine analoghe | |
ITMI20030811A1 (it) | Procedimento ed impianto per la produzione di confezioni | |
DE602004005527D1 (de) | Oberflächenemittierender Halbleiterlaser und dessen Herstellungsverfahren | |
ITMI20030346A1 (it) | Procedimento per la produzione di mesitilene. | |
ITMI20032105A1 (it) | Procedimento e dispositivo per la produzione di parti | |
ITTO20030567A1 (it) | Procedimento ed apparecchiatura per la produzione di un | |
ITBO20030267A1 (it) | Metodo ed apparecchiatura per la realizzazione di articoli | |
ITTE20030003A1 (it) | Procedimento per la realizzazione di stampi e/o matrici | |
ITMI20021429A1 (it) | Procedimento per la realizzazione di piastrelle e piastrella ottenibile mediante tale procedimento |